USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also …
Over the last 12 months, insiders at USANA Health Sciences, Inc. have bought $0 and sold $3.54M worth of USANA Health Sciences, Inc. stock.
On average, over the past 5 years, insiders at USANA Health Sciences, Inc. have bought $0 and sold $36.11M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 20,792 shares for transaction amount of $1.47M was made by WENTZ MYRON W (director) on 2017‑12‑11.
2024-08-13 | Sale | CHIEF PEOPLE OFFICER | 6,266 0.0338% | $38.38 | $240,487 | 0.00% | ||
2024-08-07 | Sale | director | 674 0.0035% | $39.69 | $26,753 | -1.89% | ||
2024-07-31 | Sale | director | 1,000 0.0053% | $44.43 | $44,430 | 0.00% | ||
2024-06-14 | Sale | 10 percent owner | 13,496 0.0676% | $45.03 | $607,725 | -11.21% | ||
2024-06-12 | Sale | 10 percent owner | 2,202 0.0117% | $47.79 | $105,234 | -13.43% | ||
2024-06-07 | Sale | 10 percent owner | 3,700 0.0199% | $48.61 | $179,857 | -15.27% | ||
2024-05-22 | Sale | CHIEF PEOPLE OFFICER | 2,714 0.0143% | $48.66 | $132,064 | -15.71% | ||
2024-05-07 | Sale | CHIEF FINANCIAL OFFICER | 5,198 0.0271% | $44.76 | $232,677 | -3.05% | ||
2024-05-07 | Sale | director | 490 0.0025% | $44.59 | $21,849 | -3.05% | ||
2024-05-02 | Sale | CHIEF COMMUNICATIONS OFFICER | 3,791 0.0197% | $47.14 | $178,717 | -5.39% | ||
2024-03-11 | Sale | EXEC. CHAIRMAN OF THE BOARD | 11,011 0.0572% | $49.00 | $539,539 | -7.77% | ||
2024-03-08 | Sale | CHIEF OPERATING OFFICER | 5,240 0.0275% | $49.05 | $257,022 | -6.75% | ||
2024-03-06 | Sale | CO. & MAN. DIR. OF CHINA | 3,810 0.0196% | $47.00 | $179,066 | -4.60% | ||
2024-03-05 | Sale | CHIEF SCIENTIFIC OFFICER | 3,945 0.0204% | $46.55 | $183,659 | -2.77% | ||
2024-03-04 | Sale | director | 300 0.0016% | $48.99 | $14,696 | -6.31% | ||
2024-03-04 | Sale | director | 491 0.0026% | $49.07 | $24,096 | -6.31% | ||
2024-03-01 | Sale | CHIEF COMMUNICATIONS OFFICER | 1,500 0.0078% | $48.08 | $72,120 | -5.96% | ||
2024-02-29 | Sale | CHIEF SALES OFFICER | 4,311 0.0226% | $47.76 | $205,872 | -5.82% | ||
2024-02-29 | Sale | director | 485 0.0026% | $48.15 | $23,351 | -5.82% | ||
2024-02-29 | Sale | CHIEF LEGAL OFFICER | 4,847 0.0255% | $47.91 | $232,234 | -5.82% |
WENTZ MYRON W | 10 percent owner | 7864345 41.2777% | $37.83 | 16 | 215 | +8.99% |
Gull Global Ltd | 10 percent owner | 9865614 51.7817% | $37.83 | 4 | 105 | +57.15% |
GULL HOLDINGS LTD | 10 percent owner | 6574167 34.5059% | $37.83 | 12 | 83 | <0.0001% |
WENTZ DAVE | Co-C.E.O. | 384883 2.0201% | $37.83 | 3 | 63 | +24.28% |
Bramble James | Chief Legal Officer and Sec | 2076 0.0109% | $37.83 | 1 | 16 | +65.07% |
BlackRock | $88.16M | 9.54 | 1.82M | -1.03% | -$919,414.53 | <0.01 | |
The Vanguard Group | $76.71M | 8.3 | 1.58M | -0.07% | -$50,925.00 | <0.01 | |
Renaissance Technologies | $59.28M | 6.42 | 1.22M | +1.97% | +$1.15M | 0.09 | |
Voya Investment Management | $38.09M | 4.12 | 785,344 | +3.12% | +$1.15M | 0.13 | |
Dimensional Fund Advisors | $32.94M | 3.57 | 679,269 | +0.24% | +$77,842.50 | 0.01 |